Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

9.990 -0.150 (-1.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,100,932
Open 10.15
Bid (Size) 10.00 (1,600)
Ask (Size) 10.10 (1,000)
Prev. Close 10.14
Today's Range 9.895 - 10.26
52wk Range 6.230 - 16.44
Shares Outstanding 157,749,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c... 
Via StockStory
News headline image
Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the pharmaceuticals industry, including Oc... 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-15.5%
-15.5%
1 Month
-9.9%
-9.9%
3 Month
+0.2%
+0.2%
6 Month
+23.3%
+23.3%
1 Year
-17.4%
-17.4%

More News

Read More
News headline image
Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
Via StockStory
Ocular Therapeutix Inc (NASDAQ:OCUL) Misses on Revenue and EPS in Q1 2026, Stock Dips ↗
Via Chartmill
News headline image
3 Russell 2000 Stocks That Concern Us
Via StockStory
News headline image
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment ↗
Via MarketBeat
News headline image
3 Cash-Burning Stocks with Open Questions
Via StockStory
Topics Artificial Intelligence
News headline image
3 Small-Cap Stocks with Open Questions
Via StockStory
News headline image
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?
Via StockStory
Topics Stocks
News headline image
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
Via StockStory
Topics Economy
News headline image
Why Ocular Therapeutix (OCUL) Stock Is Up Today
Via StockStory
News headline image
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
3 of Wall Street’s Favorite Stocks That Concern Us
Via StockStory
News headline image
1 Russell 2000 Stock to Research Further and 2 Facing Headwinds
Via StockStory
News headline image
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗
Via The Motley Fool
Topics Regulatory Compliance Stocks
News headline image
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Ocular Therapeutix (OCUL) Stock Is Nosediving
Via StockStory
News headline image
Ocular Therapeutix (NASDAQ:OCUL) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
Via StockStory
News headline image
Ocular Therapeutix (OCUL) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
News headline image
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
Via StockStory
News headline image
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools ↗
Via The Motley Fool
News headline image
What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Heavy Stock to Research Further and 2 We Brush Off
Via StockStory

Frequently Asked Questions

Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
What is the current price of Ocular Therapeutix, Inc. - Common Stock?
The current price of Ocular Therapeutix, Inc. - Common Stock is 9.990
When was Ocular Therapeutix, Inc. - Common Stock last traded?
The last trade of Ocular Therapeutix, Inc. - Common Stock was at 09/18/26 04:00 PM ET
What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.58B
How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
Ocular Therapeutix, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.